Among Hispanic Americans from different countries of origin, here are significant disparities in prostate cancer characteristics, treatment choice, and survival, based on a study of about 55,000 Hispanic American men diagnosed between 2004 and 2015.
Mexicans had the least favorable prostate cancer characteristics at diagnosis, while Cubans had the worst overall survival and were most likely to receive hormone therapy and radiation therapy and least likely to receive surgical treatment.
Compared to Mexicans, Puerto Ricans had similar overall survival, and Dominicans and South/Central Americans had better survival.
- See “Prostate Cancer Disparities in Hispanics Americans Using the National Cancer Database” on the Physician’s Weekly website (August 4, 2022)
- See the abstract of the scientific paper “Prostate Cancer Disparities in Hispanics Using the National Cancer Database” by Matthew Del Pino et al.
